Posts filtered by tags: Gilead Sciences[x]


 

Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others.

Molnupiravir is an experimental oral antiviral developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19. Merck Merck's COVID-19 pill holds tremendous promise in fighting the pandemic. Industry analysts expect Merck to make billions off the not-yet-authorized drug. Some countries will be paying $12 per pill, while the US agreed to pay $712 per treatment course. Merck is walking a tightrope with its COVID-19 pill, expecting to reap billions in revenue while still makin...
Tags: Health, Science, News, Africa, US, Trends, Merck, Joe Biden, Gotham, Harvard University, Healthcare, Middle East, Biotech, Bernstein, Gilead Sciences, Harvard Medical School


Emulate Inc closes $82M Series E to fund expansion of “organ-on-a-chip” products

Emulate Inc., a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in a “roadmap” for developing model organ systems created to fit drugmakers’ needs and bring the idea of an organ-on-a-chip into use in the lab.  An organ-on-a-chip is pretty much exactly what it sounds like: it’s a recreation of a human organ (or system of human organs) scaled down into a tiny piec...
Tags: Congress, Tech, Fda, Nih, Gilead Sciences, Corbett, Jim Corbett, Cooperative Research, Emulate Inc, Northpond Ventures, So far Emulate, Roche Genentech Johnson Johnson


Gilead Sciences Wins Reversal of $1.2 Billion Award in Patent Case With Bristol Myers

By Blake Brittain and Ankur Banerjee(Reuters) -A U.S. appeals court on Thursday threw out a $1.2 billion ruling against Gilead Sciences Inc,...
Tags: Gilead Sciences, Bristol Myers, Blake Brittain, Ankur Banerjee Reuters


Gilead Sciences Wins Reversal of $1.2 Billion Fine Against Bristol Myers in Patent Case

By Blake Brittain and Ankur Banerjee(Reuters) - U.S. biotech Gilead Sciences Inc escaped a $1.2 billion penalty after a U.S. appeals court on...
Tags: Gilead Sciences, Bristol Myers, Blake Brittain


10 Things in Politics: Biden team's wealth raises ethical concerns

Welcome back to 10 Things in Politics. Sign up here to receive this newsletter. Send tips to [email protected] or tweet me at @BrentGriffiths.Here's what we're talking about:A guide to the wealth - and potential ethical conflicts - of 31 top Biden appointeesThe number of white people in the US fell for the first time in recorded historyThe 11 best staff Twitter accounts on Capitol HillProgramming note: No newsletter on Monday, but I'll be back in your inbox first thing Tuesday.W...
Tags: Energy, Transportation, Uber, Florida, New York, Nbc, Mississippi, Supreme Court, Washington Post, Senate, White House, Virginia, Massachusetts, US, America, Trends


Get Ready For The Redistricting Wars

A lot of things happened. Here are some of the things. The Battle Begins The Census Bureau will release its redistricting data today, kicking off the inevitable fight over partisan gerrymandering ahead of the 2022 elections. States will draw and formally set their district maps at different paces (and you better believe that there’ll be legal battles galore), so we won’t know the new overall partisan makeup of the country’s districts for a while. What we do know is that most of ...
Tags: Florida, Texas, News, Washington, Oregon, West Virginia, Fbi, House, States, Rudy, Giuliani, Andrew Cuomo, Justice Department, Albany, Rudy Giuliani, Clinton


Sen. Rand Paul may have violated insider trading law by failing to disclose wife's COVID drug stock purchases

Sen. Rand Paul is administered an oath as his wife Kelley looks on during a swearing-in ceremony in the US Capitol on Jan 3, 2017. Tom Williams/CQ Roll Call A watchdog group says Sen. Rand Paul may have intentionally violated the STOCK Act, which combats insider trading. Paul's wife Kelley purchased stock in Gilead Sciences in February 2020. The Campaign Legal Center is asking the Senate Ethics Committee to investigate whether Paul intentionally violated the law. See more stories on In...
Tags: Post, Congress, Washington Post, Kentucky, Trends, Georgia, Rand Paul, World Health Organization, North Carolina, Senate Intelligence Committee, Stock, Ethics Committee, PAUL, Gilead Sciences, CLC, Loeffler


Rand Paul misses deadline by 16 months to report wife's COVID-19 treatment stock purchase

Gilead Sciences produces remdesivir, an antiviral drug that has been used to treat COVID-19. Kelley Paul invested in Gilead Sciences on Feb. 26, 2020.       [Author: Louisville Courier Journal]
Tags: News, Rand Paul, Gilead Sciences, Louisville Courier Journal, Kelley Paul, COVID


Sen. Rand Paul Discloses Wife’s Investment In Remdesivir Maker ― 16 Months Later

Kelley Paul lost money on the investment in Gilead Sciences, which makes an antiviral drug used to treat coronavirus.
Tags: News, Gilead Sciences, Kelley Paul, Sen Rand Paul Discloses Wife


Rand Paul Discloses Wife’s Investment In COVID Drug Maker Right Before The Pandemic

Kelley Paul lost money on the investment in Gilead Sciences, which makes an antiviral drug used to treat coronavirus.
Tags: News, Gilead Sciences, Kelley Paul


Rand Paul reveals in late financial disclosure his wife bought stock in company behind remdesivir in Feb. 2020

Republican Sen. Rand Paul of Kentucky revealed Wednesday that his wife in February 2020 purchased up to $15,000 in stock in Gilead Sciences, the maker of the antiviral drug remdesivir.
Tags: News, Stories, Rand Paul, Gilead Sciences, Sen Rand Paul of Kentucky


Rand Paul reveals in late financial disclosure that his wife bought stock in company behind remdesivir in February 2020

Republican Sen. Rand Paul of Kentucky revealed Wednesday that his wife in February 2020 purchased up to $15,000 in stock in Gilead Sciences, the maker of the antiviral drug remdesivir.
Tags: Cnn, Rand Paul, Gilead Sciences, Sen Rand Paul of Kentucky


Rand Paul discloses wife's investment in remdesivir parent company, 16 months later

Kelley Paul bought stock in Gilead Sciences, which manufactures remdesivir, on Feb. 26, 2020
Tags: Rand Paul, Gilead Sciences, Kelley Paul


Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year

Skye Gould/Insider Irene Jiang/Business Insider An Insider analysis of 182 biotech and pharma companies revealed that 92% of CEOs are men. The lack of diversity in the drug industry's CEO ranks costs women an estimated $532 million a year. Drug industry CEOs and other experts said equity is achievable if companies make it a priority. This article is part of a series called "The Cost of Inequity," examining the hurdles that marginalized and disenfranchised groups face acr...
Tags: Health, Science, Boston, Trends, Healthcare, Biotech, Gender Diversity, Bio, Anderson, Gilead Sciences, Cooke, Pharmaceutical, Brainard, Veracyte, Third Rock Ventures, Bonnie Anderson


Can COVID-19 Really Be Treated with a Hepatitis C Drug?

According to the World Health Organization, COVID-19 has impacted over 132 million people worldwide (as of April 2021) (1). Of those 132 million, approximately 13 million cases are located in India. India is starting to see a surge in cases and sits at the third highest caseloads behind the U.S. and Brazil. One of the leading pharmaceutical companies in India, called Cadila Healthcare Ltd, just received approval to treat COVID-19 with a hepatitis C drug. The Drug and the Outcome After results ...
Tags: Health, India, United States, Brazil, Fda, Gilead Sciences, New England Journal of Medicine, India India, Cadila Healthcare Ltd, Sarah Stanley, UC Berkeley School of Public Health, General Hepatitis C News/Updates, COVID, World Health Organization COVID, Cadila, Approved U S Treatments According to the CDC


Why AstraZeneca's vaccine will be too late for the US

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:We break down why AstraZeneca's COVID shot will come too late for the US;COVID-19 became the third leading cause of death in 2020;The first trial begins to test a vaccine that confronts concerning variants.If you're new to this newsletter, sign up here. Comments or tips? Email me at [email protected] or tweet @lydiaramsey125. Now, let's get to it...More news about the Pfizer vaccine thi...
Tags: Europe, US, Trends, Canada, South Africa, Arkansas, Healthcare, Astrazeneca, Vaccine, Getty, Nih, Variant, Gilead Sciences, CU Boulder, University of Colorado Boulder, Germany France


Pfizer's newest vaccine plant has a history of mold issues and recalls, according to FDA reports

A healthcare worker holds up a vial of the Pfizer COVID-19 vaccine. CHRIS JACKSON/POOL/AFP via Getty Images A Pfizer facility soon making COVID-19 vaccines has a history of mold and recalls, FDA reports show. The site has been the focus of at least four intense FDA inspections since Pfizer took over in 2015. A Pfizer spokesperson said improvements have been made and the site now meets FDA standards. Visit the Business section of Insider for more stories. Pfizer's management knew last y...
Tags: Health, Science, News, Congress, Trends, European Union, Healthcare, Food And Drug Administration, Kansas, Fda, Pfizer, Vaccine, Nolan, Kaiser Health News, Crowell Moring, Amgen


EU Drug Watchdog to Weigh in on Extended Use for Remdesivir by Summer

(Reuters) - Europe's drugs regulator said on Tuesday it was expecting to give an opinion before the summer on whether Gilead Sciences' remdesivir...
Tags: Gilead Sciences, Reuters Europe, EU Drug Watchdog


UH receives funding from Gilead Sciences to fight against HIV/AIDS epidemic

A University of Houston Graduate College of Social Work research center working to eradicate the underlying serious and systemic challenges that contribute to the HIV/AIDS epidemic in the Southern United States has received $5 million in renewal funding from biopharmaceutical company Gilead Sciences, Inc. to facilitate the continuation of its impactful work.
Tags: Health, Gilead Sciences, Southern United States, Gilead Sciences Inc


2021 is shaping up to be a busy year for healthcare dealmaking

Hollis Johnson/Business Insider Hello,We've made it to the end of a shorter - but no less eventful - workweek. We end the week with a new president, and I for one am looking forward to what stories emerge as President Joe Biden's policies start to impact the business of healthcare. This week, we spent our time (when not tuning into the inauguration) covering what the Biden administration's vaccine plans are, tracking the latest developments at billion-dollar startups Cityblock Health and A...
Tags: Google, Trends, Joe Biden, Healthcare, Mark Cuban, M&a, Silicon Valley, Vaccine, Biden, Shark Tank, Trump, Reuters, Jpmorgan, Blake, Gilead Sciences, Shelby


Life-threatening COVID-19 cases may be linked to 5 key genes, a study found. It's a clue about how to treat the disease.

Hospital workers processes COVID-19 specimens at UMass Memorial Hospital in Worcester, Massachusetts, on November 11, 2020. Erin Clark/The Boston Globe via Getty Images Five genes seem to be associated with life-threatening cases of COVID-19, a new study found. The finding offers a potential explanation for why some patients get severely sick while others don't. Two of these genes are linked to the innate immune response, while three are tied to inflammation and lung damage. The study offe...
Tags: UK, Science, News, US, Trends, Merck, Ap, Immune System, Genetics, Fda, Edinburgh, University of Edinburgh, Boston Globe, Gene, OAS, Gilead Sciences


The pandemic should be a 'Sputnik moment' that reverses our failure to invest in science and research, the top scientist at New York's biggest hospital system says

Feinstein Institutes for Medical Research President and CEO Kevin Tracey Northwell Health The US government needs to boost funding for research and design a nationally coordinated way to test experimental drugs in the future, a leading clinical researcher said.  "I hope that America sits up and confronts this as a Sputnik moment," said Dr. Kevin Tracey, CEO of the Feinstein Institutes for Medical Research at Northwell Health, New York's largest healthcare provider. Tracey was...
Tags: UK, New York, US, America, Trends, Prague, Food And Drug Administration, Sputnik, Who, World Health Organization, Pfizer, Soviet Union, Gilead Sciences, Tracey, Northwell Health, Northwell


The WHO will not recommend remdesivir for COVID-19 patients, since it doesn't seem to boost their chances of survival

A vial of remdesivir as seen during a news conference at the University Hospital Eppendorf in Hamburg, Germany, April 8, 2020. Ulrich Perrey/Reuters The FDA approved remdesivir as a treatment for severe COVID-19 cases last month, after granting emergency authorization in May. But on Thursday, the World Health Organization announced it will not recommend the drug's use for COVID-19 patients. "There is currently no evidence that it improves survival or the need for ventilation," the organiza...
Tags: Science, News, International, Trends, Who, World Health Organization, Fda, The New York Times, Bmj, Reuters, Brussels Belgium, University of Birmingham, Gilead Sciences, Houston Texas, Hamburg Germany, Ridley


Eli Lilly arthritis drug gets FDA nod for emergency use with remdesivir to treat Covid-19

The FDA on Thursday approved the emergency use of Eli Lilly's arthritis drug with Gilead Sciences' remdesivir to treat Covid-19 patients.
Tags: Fda, Gilead Sciences, Eli Lilly


Shot To Prevent HIV Works Better Than Daily Pill in Women

A single shot given every two months has proved to be more effective than a daily pill at preventing H.I.V. in women, researchers reported on Monday, an advance that medical experts hailed as groundbreaking in the fight against the deadly virus that causes AIDS. From a report: The finding that the long-acting drug would prevent H.I.V. in six doses taken over a year instead of the 365 required for the prevention pill currently on the market was so convincing the researchers decided to end their c...
Tags: Boston, Tech, United Nations, Truvada, Gilead Sciences, Brigham, Saharan Africa, Gilead, UNAIDS, Descovy, Kimberly Smith, HIV Works Better Than Daily Pill, Sigal Yawetz


Gilead sold $873 million worth of its antiviral COVID-19 treatment even though data on its success remains mixed

FILE PHOTO: A vial of remdesivir Reuters Gilead posted its first numbers detailing how much money the pharmaceutical company has made through Veklury, a COVID-19 antiviral treatment.  Gilead sold $873 million worth of Veklury, also known as remdesivir, in three months. The FDA authorized Veklury as the first antiviral treatment approved to treat COVID-19 patients.  Studies on the effectiveness of Veklury present mixed results. The World Health Organization tested  Veklury on more than 2,75...
Tags: News, US, Trends, Healthcare, Food And Drug Administration, Who, World Health Organization, Fda, Antiviral, Gilead Sciences, Gilead, Geoffrey Porges, Andrew Dunn, SVB Leerink, Allana Akhtar, Coronavirus


The first approved COVID-19 drug is far from 'amazing'

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello, The coronavirus pandemic is overwhelming the US yet again, with the country recording its 2 worst-ever days of infection over the weekend."We are not going to control the pandemic," White House Chief of Staff Mark Meadows said Sunday on CNN.Also in healthcare news: Gile...
Tags: Japan, UK, White House, Germany, US, Trends, Merck, Healthcare, Astrazeneca, Fda, Vaccine, University of Oxford, Donald Trump, Hamburg, Trump, University of Washington


What it'll take to get a vaccine to Americans

Hollis Johnson/Business Insider Hello,Happy Friday! We here on the healthcare team have had a big week of coronavirus vaccine and treatment developments and preparing for an election that's less than two weeks away.  Let's dive in.But first - want more updates from the healthcare team? Subscribe to this newsletter here — and tell your  friends! A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine candidate Janssen What it'll take to...
Tags: Google, Amazon, New York, US, Trends, Vc, Healthcare, Oscar, Astrazeneca, Fda, Las Vegas, Vaccines, Madison, Alexa, Digital Health, Clover


The FDA's panel of experts said its COVID-19 vaccine approval rules aren't strict enough, and could lead to vaccines being rushed out

A volunteer receives an injection from a medical worker. REUTERS/Siphiwe Sibeko The Food and Drug Administration's (FDA) panel of experts questioned the safety standards of the agency's COVID-19 vaccine approval at an advisory meeting Thursday. Independent experts in the FDA's vaccine advisory board said they were concerned about a vaccine being rushed out, and later proving unsafe or ineffective, per Bloomberg. The FDA requires a two-month follow-up after a final vaccine dose before emerg...
Tags: Trends, Bloomberg, Food And Drug Administration, Fda, Pfizer, Donald Trump, Gilead Sciences, Stanford University Medical Center, Siphiwe Sibeko, Diana Zuckerman, National Center for Health Research, COVID, Kate Duffy, Archana Chatterjee, Chicago Medical School, Amanda Cohn


Remdesivir Approved By FDA As First COVID-19 Treatment Drug

SACRAMENTO (AP/CBS13) – Remdesivir, an antiviral medicine given to hospitalized patients through an IV, was approved by U.S. regulators on Thursday as the first drug to treat COVID-19. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health. “The speed and rigor with which we have reached this milestone reflect the shared commitment of Gilead, g...
Tags: Health, News, California, Sacramento, Ap, United States, Food And Drug Administration, World Health Organization, Fda, Donald Trump, Nih, Daniel, Gilead Sciences, Gilead Sciences Inc, Gilead, U S National Institutes of Health